Amphastar Pharmaceuticals (AMPH) Short term Debt (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) recorded Short term Debt of $2.49 million in Q2 2026, up 168.4% from $927,000 a year earlier and up 48.9% from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Short term Debt (2013 - 2026) Analysis & Trends
At the end of FY2025, Amphastar Pharmaceuticals reported Short term Debt of $1.64 million, up 601.3% from FY2024.
- Annual Short term Debt has a five-year compound annual growth rate of -33.1% (FY2020 to FY2025).
- Across earlier years, Short term Debt came in at $234,000 in FY2024 (-46.3%), $436,000 in FY2023 (-85.7%), $3.05 million in FY2022 (+38.3%) and $2.2 million in FY2021 (-82.0%).
- The Q2 2026 figure is the highest quarterly Short term Debt since Q2 2023.
- On a year-over-year basis, Short term Debt has increased for five consecutive quarters, with growth averaging 227.3% over the last eight quarters.
- Peak year-over-year performance for Short term Debt in the last five years was growth of 646.0% in Q1 2026, against a decline of 98.1% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.67 million (Q1 2026), $1.64 million (Q4 2025) and $923,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Amphastar Pharmaceuticals | 1.16 Bn | 23.86 Mn | 93.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 923,000.00 |
| Jun 30, 2025 | 927,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 252,000.00 |
| Jun 30, 2024 | 249,000.00 |
| Mar 31, 2024 | 428,000.00 |
| Dec 31, 2023 | 436,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Jun 30, 2023 | 12.92 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.26 Mn |
API Access
Amphastar Pharmaceuticals Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();